Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

Biotechnology

Collaboration

Memo Therapeutics

Memo Therapeutics' headquarters in Schlieren, Switzerland

Christoph Esslinger

Gerald P. Parzmair

Jürgen Beck

Muazzam K.

Lars Spenger

Kristie Bass Clemmer

Matthieu Delincé

Matthias Hillenbrand

Maartje Verschuur

Stefan Kaufmann

Michael Hodges

Bodo Plachter

Elias Papatheodorou

Philippe Dro

Andreas Wüpper

Robert Schier

Christian Schneider

Thomas Taapken

The Research and Development team at Memo Therapeutics is focused on advancing innovative antibody therapies through rigorous scientific exploration. This team, comprised of experts in immunology and drug development, conducts groundbreaking research and collaborates on projects aimed at designing and optimizing antibodies for the treatment of infectious diseases and cancer. Their efforts are essential in translating scientific discoveries into effective clinical applications.

Research and Development

The Investor Relations team at Memo Therapeutics is dedicated to fostering strong relationships with current and potential investors, ensuring transparent communication about the company's strategic direction, financial performance, and advancements in antibody discovery. This team plays a critical role in building investor confidence and providing insights into the innovative efforts of Memo Therapeutics in immune repertoire analysis.

Investor Relations

The Leadership Team at Memo Therapeutics drives strategic decision-making and oversees the development of cutting-edge antibody discovery initiatives. Comprising key executives like the Chief Science Officer, Senior Vice President of Development, Chief Medical Officer, and Vice President of Clinical Operations, this team ensures alignment between research, clinical development, and business objectives to propel the company’s innovative therapies forward.

Leadership Team

The Development Team at Memo Therapeutics is responsible for overseeing the strategic planning and execution of antibody development projects. They ensure the successful transition of candidates from early-stage discovery through clinical development, focusing on quality control, compliance, and optimizing manufacturing processes. This team collaborates with various departments to streamline workflows, enhance product efficacy, and drive innovations in immune repertoire analysis.

Development Team

Memo Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Investor Relations

Leadership Team

Development Team

Offices

Memo Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Investor Relations

Leadership Team

Development Team

Offices

Related companies